BISTTRY18:19Live
RTALB Balance Sheet and Financial StatementsRta Laboratuvarları Biyolojik Ürünler İlaç ve Makine Sanayi Ticaret A.Ş.
Main MarketChemicals, Petroleum, Rubber and Plastics
1.86−0.12 (−6.06%)
- Volume
- TRY 48.6M
- Day range
- 1.82 – 1.95
- Previous close
- 1.98
- Market cap
- TRY 930M
Last updated: Source: Borsa Istanbul, 15-minute delayed
The latest reported financial period for RTALB is 2026/9. The table lists the last 5 periods from newest to oldest.
Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Rta Laboratuvarları Biyolojik Ürünler İlaç ve Makine Sanayi Ticaret A.Ş. (RTALB), derived from KAP financial reports. Amounts are in TRY.
Financials
| Period | Sales (Quarterly, TRY) | EBITDA (Quarterly, TRY) | Net profit (Quarterly, TRY) |
|---|---|---|---|
| 2026/9 | 95.6M | 14.3M | −233.5M |
| 2026/6 | 89.6M | −25.7M | −268.4M |
| 2026/3 | 82.6M | 13.9M | −298.3M |
| 2025/12 | 25.3M | −480.4K | 578.8M |
| 2025/9 | 75.3M | 8M | 94.4M |
Frequently Asked Questions
How much profit did RTALB report in its latest statements?
In the latest period (2026/9) RTALB reported a net profit of TRY −233.5M, sales of TRY 95.6M and EBITDA of TRY 14.3M.
What does annualised mean?
Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.